| The tumor microenvironment and its contribution to tumor evolution toward metastasis G Lorusso, C Rüegg Histochemistry and cell biology 130, 1091-1103, 2008 | 651 | 2008 |
| Evidence for the involvement of endotheliai cell integrin αVβ3 in the disruption of the tumor vascuiature induced by TNF and IFN-γ C Rüegg, A Yilmaz, G Bieler, J Bamat, P Chaubert, FJ Lejeune Nature medicine 4 (4), 408-414, 1998 | 573 | 1998 |
| Consensus guidelines for the use and interpretation of angiogenesis assays P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ... Angiogenesis 21, 425-532, 2018 | 551 | 2018 |
| Role of integrin alpha 4 beta 7/alpha 4 beta P in lymphocyte adherence to fibronectin and VCAM-1 and in homotypic cell clustering C Rüegg, AA Postigo, EE Sikorski, EC Butcher, R Pytela, DJ Erle The Journal of cell biology 117 (1), 179-189, 1992 | 436 | 1992 |
| NSAIDs inhibit αVβ3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis O Dormond, A Foletti, C Paroz, C Rüegg Nature medicine 7 (9), 1041-1047, 2001 | 384 | 2001 |
| Clinical applications of TNF-α in cancer FJ Lejeune, C Rüegg, D Liénard Current opinion in immunology 10 (5), 573-580, 1998 | 359 | 1998 |
| Efficiency of recombinant human TNF in human cancer therapy FJ Lejeune, D Liénard, M Matter, C Rüegg Cancer immunity 6 (1), 2006 | 342 | 2006 |
| Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle. EL Palmer, C Rüegg, R Ferrando, R Pytela, D Sheppard The Journal of cell biology 123 (5), 1289-1297, 1993 | 322 | 1993 |
| Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs T Calzascia, F Masson, W Di Berardino-Besson, E Contassot, R Wilmotte, ... Immunity 22 (2), 175-184, 2005 | 272 | 2005 |
| Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis C Rüegg, A Mariotti Cellular and Molecular Life Sciences CMLS 60, 1135-1157, 2003 | 248 | 2003 |
| Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis I Sofia Vala, LR Martins, N Imaizumi, RJ Nunes, J Rino, F Kuonen, ... PloS one 5 (6), e11222, 2010 | 240 | 2010 |
| Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes G Xue, DF Restuccia, Q Lan, D Hynx, S Dirnhofer, D Hess, C Rüegg, ... Cancer discovery 2 (3), 248-259, 2012 | 234 | 2012 |
| New insights into the mechanisms of organ-specific breast cancer metastasis G Lorusso, C Rüegg Seminars in cancer biology 22 (3), 226-233, 2012 | 213 | 2012 |
| Vascular integrins in tumor angiogenesis: mediators and therapeutic targets GC Alghisi, C Rüegg Endothelium 13 (2), 113-135, 2006 | 209 | 2006 |
| Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis C Rüegg, O Dormond, A Mariotti Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1654 (1), 51-67, 2004 | 206 | 2004 |
| Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase … M Bezzi, M Hasmim, G Bieler, O Dormond, C Rüegg Journal of Biological Chemistry 278 (44), 43603-43614, 2003 | 202 | 2003 |
| Prostaglandin E2 promotes integrin αVβ3-dependent endothelial cell adhesion, Rac-activation, and spreading through cAMP/PKA-dependent signaling O Dormond, M Bezzi, A Mariotti, C Ruegg Journal of Biological Chemistry 277 (48), 45838-45846, 2002 | 196 | 2002 |
| Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism S Garrido-Urbani, S Jemelin, C Deffert, S Carnesecchi, O Basset, ... PloS one 6 (2), e14665, 2011 | 195 | 2011 |
| Suppression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells: which side to target? C Rüegg, O Dormond, A Foletti Endothelium 9 (3), 151-160, 2002 | 194 | 2002 |
| Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. CR Rüegg, R Chiquet-Ehrismann, SS Alkan Proceedings of the National Academy of Sciences 86 (19), 7437-7441, 1989 | 193 | 1989 |
